Canadian COVID-19 Antibody and Health Survey (CCAHS)

Skip to filters. View results.

This follow-up to the Canadian COVID-19 Antibody and Health Survey (CCAHS - Follow-up Questionnaire, 2023) collected new and updated information about health. The questions touched on changes in vaccination status, reinfection with the virus that causes COVID-19, symptoms of COVID-19 and impact on daily life, health conditions and the use of health care services.

Results

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Type

1 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (3)

All (3) ((3 results))

  • Table: 13-10-0868-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.
    Release date: 2023-08-03

  • Table: 13-10-0866-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.
    Release date: 2023-03-27

  • Table: 13-10-0818-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description:

    Seroprevalence of Canadians aged 1 and older with antibodies against SARS-CoV-2 (the virus that causes COVID-19), overall and by antibody type, by age group and sex.

    Release date: 2021-07-06
Data (3)

Data (3) ((3 results))

  • Table: 13-10-0868-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.
    Release date: 2023-08-03

  • Table: 13-10-0866-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.
    Release date: 2023-03-27

  • Table: 13-10-0818-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description:

    Seroprevalence of Canadians aged 1 and older with antibodies against SARS-CoV-2 (the virus that causes COVID-19), overall and by antibody type, by age group and sex.

    Release date: 2021-07-06
Analysis (0)

Analysis (0) (0 results)

No content available at this time.

Reference (0)

Reference (0) (0 results)

No content available at this time.